Evidence map›Paper›PMID 35682718›Full record

ArticleInternational journal of molecular sciences2022

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas.

Guénaëlle Levallet, Fatéméh Dubois, Arthur Leclerc, Edwige Petit, Lien Bekaert, Maxime Faisant, Christian Creveuil, Evelyne Emery, Gérard Zalcman, Emmanuèle Lechapt-Zalcman

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06203496 recruitingnot on this mapstarted 2024, after this paper: background citation

Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs

TypeobservationalSponsorUniversity Hospital, CaenRan2024 to 2026Enrolled60ConditionsGlioma, MalignantArmsBlood sample
NCT06610851 recruitingnot on this mapstarted 2024, after this paper: background citation

Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA

TypeobservationalSponsorUniversity Hospital, CaenRan2024 to 2030Enrolled20ConditionsGlioma, miRNA, Low-grade Glioma, BiomarkersArmsBlood sample
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Guénaëlle LevalletNormandie University, UNICAEN, CNRS, ISTCT Unit, GIP CYCERON, F-14074 Caen, France.ORCID 0000-0001-7772-0581
Fatéméh DuboisNormandie University, UNICAEN, CNRS, ISTCT Unit, GIP CYCERON, F-14074 Caen, France.ORCID 0000-0002-1148-7497
Arthur LeclercDepartment of Neurosurgery, CHU de Caen, F-14033 Caen, France.ORCID 0000-0002-7373-1109
Edwige PetitNormandie University, UNICAEN, CNRS, ISTCT Unit, GIP CYCERON, F-14074 Caen, France.
Lien BekaertDepartment of Neurosurgery, CHU de Caen, F-14033 Caen, France.
Maxime FaisantDepartment of Pathology, CHU de Caen, F-14033 Caen, France.
Christian CreveuilBiomedical Research Unit, CHU de Caen, F-14033 Caen, France.
Evelyne EmeryDepartment of Neurosurgery, CHU de Caen, F-14033 Caen, France.
Gérard ZalcmanDepartment of Thoracic Oncology & CIC1425, Paris Cité University, Hôpital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, F-75877 Paris, France.ORCID 0000-0002-0343-9575
Emmanuèle Lechapt-ZalcmanNormandie University, UNICAEN, CNRS, ISTCT Unit, GIP CYCERON, F-14074 Caen, France.ORCID 0000-0002-8211-6167
Centre Hospitalier Universitaire de Caen Normandie · FRCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FR

Funding

APRI from the at the Caen University Hospital center 2012Ligue Nationale Contre le Cancer 2012
6 · The paper itself

Abstract

IDH (isocitrate dehydrogenase) mutation, hypoxia, and neo-angiogenesis, three hallmarks of diffuse gliomas, modulate the expression of small non-coding RNAs (miRNA). In this paper, we tested whether pro-angiogenic and/or pro-hypoxic miRNAs could be used to monitor patients with glioma. The miRNAs were extracted from tumoral surgical specimens embedded in the paraffin of 97 patients with diffuse gliomas and, for 7 patients, from a blood sample too. The expression of 10 pro-angiogenic and/or pro-hypoxic miRNAs was assayed by qRT-PCR and normalized to the miRNA expression of non-tumoral brain tissues. We confirmed in vitro that IDH in hypoxia (1% O

Indexed as

Brain NeoplasmsGliomaMicroRNAsHumansHypoxiaIsocitrate DehydrogenaseMutationIsocitrate DehydrogenaseMicroRNAsangiogenesisgliomahypoxiamiRNA

Identifiers

PMID35682718
PMCPMC9181142
OpenAlexW4281636442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.